V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10008463 | 10005092 | 1.77 | null | Adjuvant (A) | 2019-04-05 | 2019-04-23 | Chlorambucil | N | N | 10519170 | CETUXIMAB + OXALIPLATIN + MDG |
| 10008464 | 10005096 | 1.75 | 64 | null | 2018-06-11 | 2018-06-11 | IDELALISIB + RITUXIMAB | 2 | N | 10519214 | VEDEX |
| 10008465 | 10005099 | 1.7 | 61 | Palliative (P) | 2016-12-05 | 2017-03-01 | VEDex | N | N | 10519461 | HYDROXYCARBAMIDE |
| 10008466 | 10005102 | 1.8 | 71 | Curative (C) | 2017-08-19 | 2017-09-05 | Capecitabine (14 day) + Irinotecan | N | N | 10520070 | METHOTREXATE INTRATHECAL |
| 10008467 | 10005104 | 1.7 | 74 | Adjuvant (A) | 2018-06-25 | 2018-07-02 | Vinorelbine (oral) | N | N | 10520115 | CARBOPLATIN + LIPOSOMAL DOX |
| 10008468 | 10005105 | 1.84 | 108 | Palliative (P) | 2016-12-13 | 2017-01-01 | NIVOLUMAB | 2 | N | 10520306 | IRINOTECAN + MDG + PANITUMUMAB |
| 10008469 | 10005109 | 1.58 | 58.2 | Palliative (P) | 2015-05-03 | 2015-05-03 | Carboplatin + Liposomal Doxorubicin | N | N | 10520569 | ERLOTINIB |
| 10008470 | 10005114 | 1.68 | 0 | Palliative (P) | 2016-01-04 | 2016-01-07 | Bexarotene | N | N | 10521703 | IRINOTECAN |
| 10008471 | 10005115 | 1.53 | null | null | 2017-09-03 | 2017-09-03 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 10521975 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 10008472 | 10005117 | 1.78 | 53.8 | Adjuvant (A) | 2017-10-21 | 2017-10-24 | CETUXIMAB | 02 | N | 10522682 | ECF |
| 10008473 | 10005118 | null | 83.8 | Palliative (P) | 2016-07-24 | 2016-09-04 | NIVOLUMAB | N | N | 10522696 | CETUXIMAB + IRINOTECAN + MDG |
| 10008474 | 10007566 | null | 60.15 | Curative (C) | 2016-03-28 | 2016-03-28 | Capecitabine (14 day) + Irinotecan | N | N | 10524321 | DABRAFENIB + TRAMETINIB |
| 10008475 | 10005125 | 1.86 | 85 | Palliative (P) | 2018-02-23 | 2018-03-24 | Bevacizumab + Oxaliplatin +MdG | 2 | N | 10524789 | CRIZOTINIB |
| 10008476 | 10005127 | 1.7 | 78.4 | Palliative (P) | 2016-12-31 | 2017-01-21 | Capecitabine + Mitomycin | N | N | 10525059 | IVAC |
| 10008477 | 10005129 | 1.79 | null | Palliative (P) | null | 2018-06-16 | RUXOLITINIB | 02 | null | 10525819 | CETUXIMAB + IRINOTECAN + MDG |
| 10008478 | 10005130 | 1.54 | 79.4 | null | null | 2016-07-26 | DABRAFENIB | N | N | 10526084 | GEFITINIB |
| 10008479 | 10005133 | 1.75 | 91 | Palliative (P) | 2017-08-01 | 2017-10-27 | GDP | 2 | N | 10526752 | CAPECITABINE + RT |
| 10008480 | 10005137 | null | 56.6 | Not known (9) | 2018-02-23 | 2018-03-02 | Capecitabine + Mitomycin | 02 | N | 10526926 | CISPLATIN + PEMETREXED |
| 10008481 | 10005139 | 1.88 | 85 | Palliative (P) | 2017-08-04 | 2017-08-04 | CHLVPP PABLOE | N | N | 10526987 | CAPECITABINE + IRINOTECAN |
| 10008482 | 10005142 | 1.61 | 56.2 | Adjuvant (A) | 2016-12-29 | 2016-12-30 | Vinorelbine IV | N | N | 10527021 | EVEROLIMUS |
| 10008483 | 10005147 | 1.86 | 62.5 | Palliative (P) | 2015-04-27 | 2015-05-24 | CYCLO + DOXORUBICIN + VINCRISTINE | null | N | 10527747 | HYDROXYCARBAMIDE |
| 10008484 | 10005149 | 0 | null | Disease modification (D) | 2018-05-10 | 2018-08-04 | Cisplatin +Fluorouracil (3 wk) | N | N | 10527906 | FLUDARABINE |
| 10008485 | 10005151 | 1.83 | null | Adjuvant (A) | 2016-10-04 | 2017-01-31 | IVAC | N | N | 10529167 | HCX |
| 10008486 | 10005151 | 1.8 | 99.8 | Palliative (P) | 2016-10-25 | 2016-11-22 | Cytarabine High Dose | 2 | N | 10529167 | SUNITINIB |
| 10008487 | 10005153 | 1.86 | null | Palliative (P) | 2018-08-23 | 2018-08-24 | LOMUSTINE + PROCARBAZINE | 02 | N | 10530622 | R-EPOCH |
| 10008488 | 10005154 | null | null | Disease modification (D) | 2017-05-05 | 2017-05-08 | CHLORAMBUCIL + RITUXIMAB | N | N | 10530690 | CARBOPLATIN + LIPOSOMAL DOX |
| 10008489 | 10005155 | 1.85 | 69.4 | Adjuvant (A) | null | 2018-06-03 | CYCLOPHOSPHAMIDE + MITOXANTRONE + RITUXIMAB + VINCRISTINE | 02 | N | 10531127 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 10008490 | 10007578 | null | null | Disease modification (D) | 2018-06-05 | 2019-10-05 | Bortezomib +/- Dexamethasone | 02 | N | 10531378 | CAPECITABINE + IRINOTECAN |
| 10008491 | 10005158 | 1.63 | 79.8 | Palliative (P) | 2019-05-24 | 2019-06-07 | Capecitabine (21 day) + Irinotecan | N | N | 10531615 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 10008492 | 10005160 | 1.7 | 85 | Palliative (P) | null | 2017-09-10 | Brentuximab | 02 | N | 10531661 | VEPEMB |
| 10008493 | 10005163 | 1.58 | null | Palliative (P) | 2017-01-14 | 2017-01-21 | Cyclophosphamide oral | N | N | 10532185 | MPT |
| 10008494 | 10005166 | 1.84 | 63.2 | Palliative (P) | 2018-11-10 | 2018-11-17 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | N | 10532743 | IBRUTINIB + RITUXIMAB |
| 10008495 | 10005167 | 1.73 | null | Curative (C) | 2017-04-30 | 2017-09-30 | GDP | N | N | 10533072 | LOMUSTINE |
| 10008496 | 10005169 | 1.84 | 78 | Curative (C) | 2017-01-06 | 2017-01-12 | Bortezomib + Panobinostat | 02 | N | 10533229 | MELPHALAN |
| 10008497 | 10005170 | 0 | 91.6 | Palliative (P) | 2017-10-24 | 2018-03-14 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 10533451 | CISPLATIN + FLUOROURACIL |
| 10008498 | 10005171 | 1.76 | 100.85 | Palliative (P) | 2018-06-01 | 2018-06-15 | CISPLATIN + FLUOROURACIL | 02 | N | 10533576 | R CODOX-M/ R IVAC |
| 10008499 | 10005175 | 1.54 | null | Curative (C) | 2018-07-03 | 2018-07-03 | Liposomal Doxorubicin 50mg/m2 | N | N | 10534514 | CISPLATIN + FLUOROURACIL |
| 10008500 | 10005180 | 1.67 | 95.6 | Palliative (P) | 2018-11-19 | 2018-12-25 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | N | N | 10534701 | ENZALUTAMIDE |
| 10008501 | 10005181 | 1.99 | 70 | Adjuvant (A) | 2018-06-04 | 2018-06-18 | MaxiCHOP (Cycle 1) | 02 | N | 10534712 | ESHAP |
| 10008502 | 10007590 | 1.7 | 0 | Palliative (P) | 2017-04-14 | 2017-04-14 | UKALL14- Maintenance | N | N | 10535352 | CETUXIMAB + IRINOTECAN + MDG |
| 10008503 | 10007590 | 1.6 | 61.4 | Curative (C) | 2017-06-29 | 2017-07-09 | Docetaxel + Nintedanib | 2 | N | 10535352 | CISPLATIN |
| 10008504 | 10005186 | 1.78 | 104 | Palliative (P) | 2016-06-28 | 2016-06-28 | AML18 PILOT TRIAL | 02 | N | 10535624 | CETUXIMAB |
| 10008505 | 10005189 | 1.67 | 76.8 | Palliative (P) | 2017-06-14 | 2017-07-13 | PIN TRIAL | 2 | N | 10535646 | CISPLATIN + GEMCITABINE |
| 10008506 | 10005191 | 0 | null | Curative (C) | 2019-03-07 | 2019-03-07 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 10536379 | ECARBOX |
| 10008507 | 10005194 | 0 | null | Palliative (P) | 2014-04-27 | 2014-05-10 | CAPECITABINE + IRINOTECAN | null | N | 10536442 | CARBOPLATIN + LIPOSOMAL DOX |
| 10008508 | 10005197 | 1.68 | 52.7 | Palliative (P) | 2016-12-13 | 2016-12-22 | R Chlorambucil | N | N | 10536600 | PILOT TRIAL |
| 10008509 | 10005198 | 1.75 | 73.6 | Palliative (P) | 2017-09-05 | 2018-12-05 | Everolimus 10mg | N | N | 10536766 | LIPOSOMAL DOXORUBICIN |
| 10008510 | 10005200 | 1.72 | 88.6 | Palliative (P) | 2015-08-18 | 2015-09-27 | VEPEMB | N | null | 10536813 | EOX |
| 10008511 | 10005203 | 1.85 | 61.4 | Curative (C) | 2019-12-17 | 2019-12-18 | Hydroxycarbamide | 02 | N | 10537261 | LOMUSTINE + PROCARBAZINE |
| 10008512 | 10005205 | 1.78 | 81 | Disease modification (D) | 2018-05-02 | 2018-05-14 | CABOZANTINIB | 2 | N | 10537310 | BUSULPHAN |